N,N,N-三甲基-2-[(二甲氨基)甲酰氧基]苯铵甲磺酸盐
PI-103
产品编号.: | A935749 | CAS号: | 371935-74-9 |
分子式: | C19H16N4O3 | 分子量: | 348.3553 |
纯度: | 98% | MDL NO.: |
中文名称:N,N,N-三甲基-2-[(二甲氨基)甲酰氧基]苯铵甲磺酸盐
CAS号:371935-74-9
中文别名:PI 103 盐酸盐;PI 3-激酶抑制剂;PI-103 抑制剂;犬尿素;3-[4-(4-吗啉基吡啶并[3',2',4,5]呋喃并[3,2-d]嘧啶-2-基]苯酚
英文名称:PI-103
英文别名:PI 103 hydrochloride;PI-103;3-(4-morpholin-4-ylpyrido[2,3]furo[2,4-b]pyrimidin-2-yl)phenol;3-[4-(4-MORPHOLINYLPYRIDO)[3',2':4,5]FURO[3,2-D]PYRIMIDIN-2-YL]PHENOL HYDROCHLORIDE;Name: Y 27632;Phenol, 3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]-;PI 103;PI-103 (FREE BASE) (PI 103);X6K;PI103;3-(4-morpholinopyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl)phenol;YQX02F616F;AK163162;3-[4-(4-Morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenol;3-(4-Morpholin-4-Ylpyrido[3',2':4,5]furo[3,2-D]pyrimidin-2-Yl)phenol;Phenol, 3-(4-(4-morpholinyl)pyrido(3',2':4,5)furo(3,2-d)pyrimidin-2-yl)-;s1038;PIK-103;NSC-776996;BCP19373;NCGC00187906-03;371935-74-9 (free base);NCGC00187906-01;BRD-K67868012-003-01-5;3-[6-(morpholin-4-yl)-8-oxa-3,5,10-triazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2,4,6,10,12-hexaen-4-yl]phenol;NSC-759676;BCP01923;HMS3650M10;3-[4-(4-morpholinyl)-2-pyrido[2,3]furo[2,4-b]pyrimidinyl]phenol;3-(4-morpholinopyrido[2,3]furo[2,4-b]pyrimidin-2-yl)phenol;compound 2 [PMID: 17601739];3-(4-morpholin-4-ylpyrido[3 ,2 :4,5]furo[3,2-d]pyrimidin-2-yl)phenol;MFCD11983145;Kinome_3597;CCG-101301;SW218117-2;AC-31514;SCHEMBL258242;HMS3654E09;EX-A039;BCPP000107;SMR002530603;CHEMBL573339;HMS3295E19;HY-10115;4l23;FT-0712341;3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl];cid_9884685;AMY23717;PI-103 HCl;3-[4-(morpholin-4-yl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenol;CHEBI:90524;NSC776996;HMS3244E11;3-(4-(4-morpholinyl)pyrido[3?,2?:4,5]furo[3,2-d]pyrimidin-2- yl)phenol;NCGC00187906-02;HMS3244E12;DTXSID40190676;mTOR Inhibitor, PI103;MLS006010988;AKOS024462563;371935-74-9;3-[6-(morpholin-4-yl)-8-oxa-3,5,10-triazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl]phenol;TUVCWJQQGGETHL-UHFFFAOYSA-N;AS-16221;UNII-YQX02F616F;3-[6-(morpholin-4-yl)-8-oxa-3,5,10-triazatricyclo[7.4.0.0^{2,7}]trideca-1(13),2,4,6,9,11-hexaen-4-yl]phenol;2x6k;BDBM25045;GTPL5701;pyridofuropyrimidine derivative, 2;3-(6-morpholin-4-yl-8-oxa-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl)phenol;NCGC00187906-15;NSC759676;SR-01000946304;PI-103 hydrobromide;HMS3244F11;PI 103 hydrobromide;CS-0127;HMS3229C15;PIK 103;PI 3-K Inhibitor V;Q27088379;PI 3-K Inhibitor V;SR-01000946304-1;Q27088379;3-[4-(4-Morpholinylpyrido[3',2',4,5]furo[3,2-d]pyrimidin-2-yl]phenol;SR-01000946304-1;3-[4-(4-Morpholinylpyrido[3',2',4,5]furo[3,2-d]pyrimidin-2-yl]phenol;3-[6-(MORPHOLIN-4-YL)-8-OXA-3,5,10-TRIAZATRICYCLO[7.4.0.0(2),?]TRIDECA-1(9),2(7),3,5,10,12-HEXAEN-4-YL]PHENOL;BRD-K67868012-001-07-6;SDCCGSBI-0086698.P006;3-[4-Morpholin-4-ylpyrido[3',2':4,5]furo[3,2-d]pyriMidin-2-yl]phenol;PI-103?;BRD-K67868012-003-02-3
EINEC:
分子式:C19H16N4O3
分子量:348.3553
CAS号:371935-74-9
中文别名:PI 103 盐酸盐;PI 3-激酶抑制剂;PI-103 抑制剂;犬尿素;3-[4-(4-吗啉基吡啶并[3',2',4,5]呋喃并[3,2-d]嘧啶-2-基]苯酚
英文名称:PI-103
英文别名:PI 103 hydrochloride;PI-103;3-(4-morpholin-4-ylpyrido[2,3]furo[2,4-b]pyrimidin-2-yl)phenol;3-[4-(4-MORPHOLINYLPYRIDO)[3',2':4,5]FURO[3,2-D]PYRIMIDIN-2-YL]PHENOL HYDROCHLORIDE;Name: Y 27632;Phenol, 3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]-;PI 103;PI-103 (FREE BASE) (PI 103);X6K;PI103;3-(4-morpholinopyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl)phenol;YQX02F616F;AK163162;3-[4-(4-Morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenol;3-(4-Morpholin-4-Ylpyrido[3',2':4,5]furo[3,2-D]pyrimidin-2-Yl)phenol;Phenol, 3-(4-(4-morpholinyl)pyrido(3',2':4,5)furo(3,2-d)pyrimidin-2-yl)-;s1038;PIK-103;NSC-776996;BCP19373;NCGC00187906-03;371935-74-9 (free base);NCGC00187906-01;BRD-K67868012-003-01-5;3-[6-(morpholin-4-yl)-8-oxa-3,5,10-triazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2,4,6,10,12-hexaen-4-yl]phenol;NSC-759676;BCP01923;HMS3650M10;3-[4-(4-morpholinyl)-2-pyrido[2,3]furo[2,4-b]pyrimidinyl]phenol;3-(4-morpholinopyrido[2,3]furo[2,4-b]pyrimidin-2-yl)phenol;compound 2 [PMID: 17601739];3-(4-morpholin-4-ylpyrido[3 ,2 :4,5]furo[3,2-d]pyrimidin-2-yl)phenol;MFCD11983145;Kinome_3597;CCG-101301;SW218117-2;AC-31514;SCHEMBL258242;HMS3654E09;EX-A039;BCPP000107;SMR002530603;CHEMBL573339;HMS3295E19;HY-10115;4l23;FT-0712341;3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl];cid_9884685;AMY23717;PI-103 HCl;3-[4-(morpholin-4-yl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenol;CHEBI:90524;NSC776996;HMS3244E11;3-(4-(4-morpholinyl)pyrido[3?,2?:4,5]furo[3,2-d]pyrimidin-2- yl)phenol;NCGC00187906-02;HMS3244E12;DTXSID40190676;mTOR Inhibitor, PI103;MLS006010988;AKOS024462563;371935-74-9;3-[6-(morpholin-4-yl)-8-oxa-3,5,10-triazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl]phenol;TUVCWJQQGGETHL-UHFFFAOYSA-N;AS-16221;UNII-YQX02F616F;3-[6-(morpholin-4-yl)-8-oxa-3,5,10-triazatricyclo[7.4.0.0^{2,7}]trideca-1(13),2,4,6,9,11-hexaen-4-yl]phenol;2x6k;BDBM25045;GTPL5701;pyridofuropyrimidine derivative, 2;3-(6-morpholin-4-yl-8-oxa-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl)phenol;NCGC00187906-15;NSC759676;SR-01000946304;PI-103 hydrobromide;HMS3244F11;PI 103 hydrobromide;CS-0127;HMS3229C15;PIK 103;PI 3-K Inhibitor V;Q27088379;PI 3-K Inhibitor V;SR-01000946304-1;Q27088379;3-[4-(4-Morpholinylpyrido[3',2',4,5]furo[3,2-d]pyrimidin-2-yl]phenol;SR-01000946304-1;3-[4-(4-Morpholinylpyrido[3',2',4,5]furo[3,2-d]pyrimidin-2-yl]phenol;3-[6-(MORPHOLIN-4-YL)-8-OXA-3,5,10-TRIAZATRICYCLO[7.4.0.0(2),?]TRIDECA-1(9),2(7),3,5,10,12-HEXAEN-4-YL]PHENOL;BRD-K67868012-001-07-6;SDCCGSBI-0086698.P006;3-[4-Morpholin-4-ylpyrido[3',2':4,5]furo[3,2-d]pyriMidin-2-yl]phenol;PI-103?;BRD-K67868012-003-02-3
EINEC:
分子式:C19H16N4O3
分子量:348.3553
搜索质检报告(COA)
搜索MSDS